Diametric Capital’s Novartis NVS Stock Holding History

Diametric Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-28,510	Closed	-$2.7M	–	150
2019 Q4	$2.7M	Buy	+28,510	New	+$2.56M	1.97%	10
2019 Q3	–	Sell	-63,941	Closed	-$5.84M	–	124
2019 Q2	$5.84M	Buy	63,941 +16,848	+36%	+$1.43M	3.7%	2
2019 Q1	$3.57M	Buy	47,093 +15,791	+50%	+$1.27M	2.8%	6
2018 Q4	$2.41M	Buy	31,302 +23,386	+295%	+$1.82M	1.86%	16
2018 Q3	$611K	Buy	+7,916	New	+$585K	0.53%	66

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Diametric Capital's NVS Position: Q1 2020 in Review

Diametric Capital sold out of Novartis (NVS) in Q1 2020, closing a stake of 28,510 shares — an estimated $2.7M sold.

Diametric Capital first reported a position in NVS in Q3 2018 and held it in 5 quarters. The position peaked at $5.84M in Q2 2019. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

Diametric Capital reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
Diametric Capital sold 28,510 Novartis shares in Q1 2020, an estimated $2.7M.
Diametric Capital first reported a position in Novartis in Q3 2018 and held it in 5 quarters.
Diametric Capital's Novartis position peaked at $5.84M in Q2 2019.
1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Diametric Capital's 13F filing for Q1 2020, filed 15 May 2020.